Vor Biopharma

$4.27 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Vor Biopharma

Vor BioPharma Inc. operates as a clinical stage cell therapy company. The Company specializes in developing novel therapies for treating cancer. Vor BioPharma focuses on discovering technologies that can enable selective targeting of cancer cells without impacting normal cells. Vor BioPharma serves customers in the United States.

Stock Analysis

last close $4.22
1-mo return -26.6%
3-mo return -54.8%
avg daily vol. 96.5T
52-week high 23.79
52-week low 4.01
market cap. $159M
forward pe -
annual div. -
roe -44.5%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 83.2%

Subscribe now for daily local and international financial news